| Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma F Jundt, I Anagnostopoulos, R Förster, S Mathas, H Stein, B Dörken Blood, The Journal of the American Society of Hematology 99 (9), 3398-3403, 2002 | 567 | 2002 |
| Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-κB S Mathas, M Hinz, I Anagnostopoulos, D Krappmann, A Lietz, F Jundt, ... The EMBO journal 21 (15), 4104-4113, 2002 | 459 | 2002 |
| Overexpression of I kappa B alpha without inhibition of NF-κB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells F Emmerich, M Meiser, M Hummel, G Demel, HD Foss, F Jundt, S Mathas, ... Blood, The Journal of the American Society of Hematology 94 (9), 3129-3134, 1999 | 367 | 1999 |
| Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells F Jundt, KS Pröbsting, I Anagnostopoulos, G Muehlinghaus, ... Blood 103 (9), 3511-3515, 2004 | 305 | 2004 |
| c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor–induced apoptosis S Mathas, A Lietz, I Anagnostopoulos, F Hummel, B Wiesner, M Janz, ... The Journal of experimental medicine 199 (8), 1041-1052, 2004 | 268 | 2004 |
| Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S Mathas, M Janz, F Hummel, M Hummel, B Wollert-Wulf, S Lusatis, ... Nature immunology 7 (2), 207-215, 2006 | 250 | 2006 |
| Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S Mathas, A Lietz, M Janz, M Hinz, F Jundt, C Scheidereit, K Bommert, ... Blood 102 (3), 1028-1034, 2003 | 210 | 2003 |
| Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils F Jundt, I Anagnostopoulos, K Bommert, F Emmerich, G Müller, HD Foss, ... Blood, The Journal of the American Society of Hematology 94 (6), 2065-2071, 1999 | 192 | 1999 |
| A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein β and NF-κB activity in Hodgkin and anaplastic … F Jundt, N Raetzel, C Müller, CF Calkhoven, K Kley, S Mathas, A Lietz, ... Blood 106 (5), 1801-1807, 2005 | 168 | 2005 |
| Elevated NF-κB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas S Mathas, K Jöhrens, S Joos, A Lietz, F Hummel, M Janz, F Jundt, ... Blood 106 (13), 4287-4293, 2005 | 157 | 2005 |
| Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α B Lamprecht, S Kreher, I Anagnostopoulos, K Jöhrens, G Monteleone, ... Blood, The Journal of the American Society of Hematology 112 (8), 3339-3347, 2008 | 146 | 2008 |
| Loss of PU. 1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease F Jundt, K Kley, I Anagnostopoulos, K Schulze Pröbsting, A Greiner, ... Blood, The Journal of the American Society of Hematology 99 (8), 3060-3062, 2002 | 137 | 2002 |
| Sp1 as G1 cell cycle phase specific transcription factor in epithelial cells E Grinstein, F Jundt, I Weinert, P Wernet, HD Royer Oncogene 21 (10), 1485-1492, 2002 | 137 | 2002 |
| Differential Eµ enhancer activity and expression of BOB. 1/OBF. 1, Oct2, PU. 1, and immunoglobulin in reactive B‐cell populations, B‐cell non‐Hodgkin lymphomas, and Hodgkin … C Loddenkemper, I Anagnostopoulos, M Hummel, K Jöhrens‐Leder, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2004 | 127 | 2004 |
| Interactions between muscle and bone—where physics meets biology M Herrmann, K Engelke, R Ebert, S Müller-Deubert, M Rudert, F Ziouti, ... Biomolecules 10 (3), 432, 2020 | 120 | 2020 |
| Stroma-mediated dysregulation of myelopoiesis in mice lacking IκBα RA Rupec, F Jundt, B Rebholz, B Eckelt, T Herzinger, MJ Flaig, ... Immunity 22 (4), 479-491, 2005 | 120 | 2005 |
| Pathogenic long-lived plasma cells and their survival niches in autoimmunity, malignancy, and allergy O Winter, C Dame, F Jundt, F Hiepe The Journal of Immunology 189 (11), 5105-5111, 2012 | 116 | 2012 |
| Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed–Sternberg cells R Schwarzer, B Dörken, F Jundt Leukemia 26 (4), 806-813, 2012 | 115 | 2012 |
| Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma F Jundt, Ö Acikgöz, SH Kwon, R Schwarzer, I Anagnostopoulos, ... Leukemia 22 (8), 1587-1594, 2008 | 104 | 2008 |
| A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoter T Bauknecht, F Jundt, I Herr, T Oehler, H Delius, Y Shi, P Angel, ... Journal of virology 69 (1), 1-12, 1995 | 99 | 1995 |
Ioannis AnagnostopoulosVerified email at charite.de
